PIQLF (Proteomics International Laboratories) 5-Year EBITDA Growth Rate: -37.90% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PIQLF Proteomics International Laboratories Ltd PIQLF
31 GF Score
Price $0.26
GF Value $0.64
! 3 Warning Signs
View Full Analysis

What is Proteomics International Laboratories 5-Year EBITDA Growth Rate?

Proteomics International Laboratories PIQLF -16.13% 31 5-Year EBITDA Growth Rate is -37.90% as of Dec. 2025. GuruFocus rates PIQLF with a GF Score™ of 31/100 and a GF Value™ of $0.64. The stock has 3 warning signs investors should review.

Proteomics International Laboratories's EBITDA per Share for the six months ended in Dec. 2025 was $-0.03.

During the past 3 years, the average EBITDA Per Share Growth Rate was -19.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -37.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Proteomics International Laboratories was 22.60% per year. The lowest was -64.30% per year. And the median was -14.95% per year.

Proteomics International Laboratories  (OTCPK:PIQLF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Proteomics International Laboratories 5-Year EBITDA Growth Rate Related Terms

PIQLF vs VRTX, REGN, ALNY: 5-Year EBITDA Growth Rate Comparison

For the Biotechnology subindustry, Proteomics International Laboratories's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteomics International Laboratories 5-Year EBITDA Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's 5-Year EBITDA Growth Rate falls into.


PIQLF
31GF Score
Proteomics International Laboratories Ltd PIQLF
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Proteomics International Laboratories 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of -37.90% mean?
Proteomics International Laboratories (PIQLF) has a 5-Year EBITDA Growth Rate of -37.90% as of Dec. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Proteomics International Laboratories and its competitors.
Is Proteomics International Laboratories' 5-Year EBITDA Growth Rate too high?
Proteomics International Laboratories' current 5-Year EBITDA Growth Rate is -37.90%. Overall, Proteomics International Laboratories has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Proteomics International Laboratories' 5-Year EBITDA Growth Rate compare to VRTX and REGN?
Proteomics International Laboratories' 5-Year EBITDA Growth Rate of -37.90% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Biotechnology company?
A good 5-Year EBITDA Growth Rate depends on the Biotechnology industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Proteomics International Laboratories and its competitors. Proteomics International Laboratories's current 5-Year EBITDA Growth Rate is -37.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteomics International Laboratories stock overvalued right now?
Proteomics International Laboratories (PIQLF) has a current 5-Year EBITDA Growth Rate of -37.90%. The stock's GF Value™ is $0.64, compared to a current price of $0.26 — trading 59.4% below its estimated fair value. The current 5-Year EBITDA Growth Rate is -37.90%. Proteomics International Laboratories' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Proteomics International Laboratories (PIQLF), the current 5-Year EBITDA Growth Rate is -37.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Proteomics International Laboratories (PIQLF) Overvalued in 2026?

Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued. The current stock price of $0.26 is trading 59.4% below its estimated GF Value™ of $0.64.

Key valuation signals for PIQLF:

  • 5-Year EBITDA Growth Rate: -37.90%
  • GF Value™: $0.64 vs. price of $0.26 (59.4% below fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the PIQLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Proteomics International Laboratories Business Description

Other Exchanges PIQ:Australia
Address 6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
31GF Score

Get the complete analysis for PIQLF

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.64
GF Value